Scotland issues new framework to help reduce the risk of developing type 2 diabetes

Scotland issues new framework to help reduce the risk of developing type 2 diabetes

July 20 2018 A new framework emphasising weight management as part of the drive to reduce the...

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected...

APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

  • Scotland issues new framework to help reduce the risk of developing type 2 diabetes

    Scotland issues new framework to help reduce the risk of developing type 2 diabetes

    Friday, 20 July 2018 14:36
  • MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    Thursday, 19 July 2018 10:29
  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

patient outcomesMay 23 2016

The Royal Pharmaceutical Society is supporting work to help raise awareness about the impact workplace pressures can have on people working in primary care.

Mind, the mental health charity, wants to film primary care staff who are willing to discuss the pressures they face, how it affects their own mental health and also to share experiences about getting support. The film will be part of a campaign to improve the mental health support within primary care, said the RPS.

“We understand that the pressures on primary care are not just impacting on the mental health of patients, but also on the staff working in these services,” it added. Recent surveys of primary care staff have “uncovered high rates of burn out and unmanageable stress amongst GPs, and other primary care staff including practice nurses, pharmacists, practice managers and receptionists.”

To help highlight the issue and to support the Mind campaign, the Society is asking for members’ to consider participating in the filming. Contributions will be used “to highlight the need to address pressures in primary care and to ensure all primary care staff get support for their own mental health. We’ll be using this film to ask others to tell us how Mind could support the mental health of primary care staff.”

People will be selected by Mind after completing a form and giving a brief outline of their experiences and why they would like to appear in the film.

Links:

RPS announcement

Mind

Practice News

July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...